DLHC
Undervalued by 170.7% based on the discounted cash flow analysis.
Market cap | $125.66 Million |
---|---|
Enterprise Value | $288.15 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.11 |
Beta | 1.14 |
Outstanding Shares | 14,232,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 51.01 |
---|---|
PEG | -98.96 |
Price to Sales | 0.21 |
Price to Book Ratio | 0.5 |
Enterprise Value to Revenue | 0.76 |
Enterprise Value to EBIT | 13.31 |
Enterprise Value to Net Income | 53 |
Total Debt to Enterprise | 0.56 |
Debt to Equity | 1.44 |
No data
No data
DLH is a comprehensive health solutions and services provider that delivers a full range of technology-enabled health services across various civilian agencies, the military health system, and the Veterans Administration. The Company's s...